CCC

CLINICAL LASERTHERMIA SYSTEMS AB SER. B

No trades
See on Supercharts

CLS_B fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Clinical Laserthermia Systems AB engages in the development and manufacture of pharmaceutical products. It offers TRANBERG, a Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors that is marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy. The company was founded by Karl-Göran Tranberg, Lars-Erik Thomas Eriksson, and Per-Hakan Henriksson on March 9, 2006 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CLS_B does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company